HK1037531A1 - Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation method - Google Patents
Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation methodInfo
- Publication number
- HK1037531A1 HK1037531A1 HK01108330A HK01108330A HK1037531A1 HK 1037531 A1 HK1037531 A1 HK 1037531A1 HK 01108330 A HK01108330 A HK 01108330A HK 01108330 A HK01108330 A HK 01108330A HK 1037531 A1 HK1037531 A1 HK 1037531A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antifungic
- compound
- preparation
- coat
- acitivity
- Prior art date
Links
- 230000001716 anti-fugal effect Effects 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title 2
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000002663 nebulization Methods 0.000 abstract 2
- 239000002736 nonionic surfactant Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801539A ES2157731B1 (es) | 1998-07-21 | 1998-07-21 | Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion. |
PCT/ES1999/000230 WO2000004881A1 (es) | 1998-07-21 | 1999-07-20 | Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1037531A1 true HK1037531A1 (en) | 2002-02-15 |
Family
ID=8304581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01108330A HK1037531A1 (en) | 1998-07-21 | 2001-11-27 | Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation method |
Country Status (31)
Country | Link |
---|---|
US (1) | US6737082B1 (de) |
EP (1) | EP1103252B1 (de) |
JP (1) | JP4190732B2 (de) |
KR (1) | KR100572135B1 (de) |
AT (1) | ATE234077T1 (de) |
AU (1) | AU750730B2 (de) |
BG (1) | BG65187B1 (de) |
BR (1) | BR9912300A (de) |
CA (1) | CA2337509C (de) |
CZ (1) | CZ291938B6 (de) |
DE (1) | DE69905905T2 (de) |
DK (1) | DK1103252T3 (de) |
EE (1) | EE04415B1 (de) |
ES (2) | ES2157731B1 (de) |
HK (1) | HK1037531A1 (de) |
HR (1) | HRP20010128B1 (de) |
HU (1) | HU228895B1 (de) |
IL (1) | IL140910A (de) |
ME (1) | MEP26708A (de) |
MX (1) | MXPA01000681A (de) |
NO (1) | NO320054B1 (de) |
NZ (1) | NZ509886A (de) |
PL (1) | PL194740B1 (de) |
PT (1) | PT1103252E (de) |
RS (1) | RS50063B (de) |
RU (1) | RU2209628C2 (de) |
SK (1) | SK283279B6 (de) |
TR (1) | TR200100177T2 (de) |
UA (1) | UA64009C2 (de) |
WO (1) | WO2000004881A1 (de) |
ZA (1) | ZA200101293B (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT877563E (pt) * | 1996-01-31 | 2004-08-31 | Univ South Alabama | Preparacoes alimentares e vitaminicas contendo o isomero natural de folatos reduzidos |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
SK8562002A3 (en) | 1999-12-23 | 2003-10-07 | Pfizer Prod Inc | Pharmaceutical compositions providing enhanced drug concentrations |
FR2842736B1 (fr) | 2002-07-26 | 2005-07-22 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s) |
US20040115287A1 (en) * | 2002-12-17 | 2004-06-17 | Lipocine, Inc. | Hydrophobic active agent compositions and methods |
DK1438961T4 (da) * | 2003-01-14 | 2014-11-17 | Acino Pharma Ag | Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer |
PT1438960E (pt) * | 2003-01-14 | 2007-06-19 | Cimex Pharma Ag | Composição de itraconazole disperso num polímero hidrofílico possuindo biodisponibilidade melhorada |
FR2852607B1 (fr) * | 2003-03-20 | 2006-07-14 | Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications | |
FR2857591B1 (fr) * | 2003-07-17 | 2007-11-02 | Ethypharm Sa | Particules comprenant un principe actif sous forme de co-precipite |
ES2667668T3 (es) * | 2003-07-17 | 2018-05-14 | Janssen Sciences Ireland Uc | Procedimiento para preparar partículas que contienen un antiviral |
FR2883179B1 (fr) | 2005-03-18 | 2009-04-17 | Ethypharm Sa | Comprime enrobe |
EP2404602A1 (de) | 2005-08-22 | 2012-01-11 | The Johns Hopkins University | Hedgehog Antagonisten zur Behandlung von Krebs |
CN101283984B (zh) * | 2007-04-12 | 2010-05-26 | 永胜药品工业股份有限公司 | 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物 |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
WO2011107466A2 (de) * | 2010-03-05 | 2011-09-09 | Basf Se | Schmelzüberzogene arzneiformen |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
MA40982A (fr) * | 2014-11-19 | 2017-09-26 | Biogen Ma Inc | Formulation de bille pharmaceutique comprenant du fumarate de diméthyle |
RU2017141029A (ru) * | 2015-05-25 | 2019-06-25 | Сан Фармасьютикал Индастриз Лимитед | Фармацевтическая пероральная композиция изотретиноина для применения один раз в сутки |
AU2017310506B2 (en) | 2016-08-11 | 2019-11-21 | Dmk Pharmaceuticals Corporation | Drug compositions |
US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
US11564910B2 (en) | 2017-12-08 | 2023-01-31 | Adamis Pharmaceuticals Corporation | Drug compositions |
CN112313289A (zh) * | 2018-04-27 | 2021-02-02 | 凸版印刷株式会社 | 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸 |
WO2023118082A1 (en) * | 2021-12-22 | 2023-06-29 | Palau Pharma, S.L.U. | Multiparticulate albaconazole composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
US4916134A (en) * | 1987-03-25 | 1990-04-10 | Janssen Pharmacuetica N.V. | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones |
IE61651B1 (en) * | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
EA001219B1 (ru) * | 1996-05-20 | 2000-12-25 | Жансен Фармасетика Н.В. | Антигрибковые композиции с улучшенной биологической доступностью |
DE69710729T2 (de) * | 1996-05-24 | 2002-08-14 | Schering Corp., Kenilworth | Fungizide zusammensetzung mit erhörter bioverfügbarkeit |
CA2258683C (en) * | 1996-06-28 | 2007-07-31 | Schering Corporation | Oral composition comprising a triazole antifungal compound |
DE19626924C2 (de) * | 1996-07-04 | 1999-08-19 | Epazon B V | Gerät zur Bereitstellung eines Atemgases |
KR100520936B1 (ko) | 1997-03-26 | 2005-10-17 | 얀센 파마슈티카 엔.브이. | 항진균제 및 중합체로 코팅된 코어를 갖는 펠릿제 |
-
1998
- 1998-07-21 ES ES009801539A patent/ES2157731B1/es not_active Expired - Fee Related
-
1999
- 1999-07-20 UA UA2001021260A patent/UA64009C2/uk unknown
- 1999-07-20 DE DE69905905T patent/DE69905905T2/de not_active Expired - Lifetime
- 1999-07-20 JP JP2000560874A patent/JP4190732B2/ja not_active Expired - Fee Related
- 1999-07-20 WO PCT/ES1999/000230 patent/WO2000004881A1/es not_active Application Discontinuation
- 1999-07-20 RS YUP-39/01A patent/RS50063B/sr unknown
- 1999-07-20 EP EP99931261A patent/EP1103252B1/de not_active Expired - Lifetime
- 1999-07-20 SK SK86-2001A patent/SK283279B6/sk not_active IP Right Cessation
- 1999-07-20 ME MEP-267/08A patent/MEP26708A/xx unknown
- 1999-07-20 EE EEP200100041A patent/EE04415B1/xx not_active IP Right Cessation
- 1999-07-20 PL PL99345625A patent/PL194740B1/pl not_active IP Right Cessation
- 1999-07-20 KR KR1020017000783A patent/KR100572135B1/ko not_active IP Right Cessation
- 1999-07-20 TR TR2001/00177T patent/TR200100177T2/xx unknown
- 1999-07-20 IL IL14091099A patent/IL140910A/en not_active IP Right Cessation
- 1999-07-20 CZ CZ2001175A patent/CZ291938B6/cs not_active IP Right Cessation
- 1999-07-20 BR BR9912300-2A patent/BR9912300A/pt not_active Application Discontinuation
- 1999-07-20 ES ES99931261T patent/ES2194480T3/es not_active Expired - Lifetime
- 1999-07-20 DK DK99931261T patent/DK1103252T3/da active
- 1999-07-20 MX MXPA01000681A patent/MXPA01000681A/es active IP Right Grant
- 1999-07-20 RU RU2001104894/14A patent/RU2209628C2/ru not_active IP Right Cessation
- 1999-07-20 CA CA002337509A patent/CA2337509C/en not_active Expired - Fee Related
- 1999-07-20 NZ NZ509886A patent/NZ509886A/xx not_active IP Right Cessation
- 1999-07-20 HU HU0103708A patent/HU228895B1/hu not_active IP Right Cessation
- 1999-07-20 AT AT99931261T patent/ATE234077T1/de active
- 1999-07-20 US US09/744,322 patent/US6737082B1/en not_active Expired - Fee Related
- 1999-07-20 PT PT99931261T patent/PT1103252E/pt unknown
- 1999-07-20 AU AU47821/99A patent/AU750730B2/en not_active Ceased
-
2001
- 2001-01-17 NO NO20010289A patent/NO320054B1/no not_active IP Right Cessation
- 2001-02-15 ZA ZA200101293A patent/ZA200101293B/en unknown
- 2001-02-21 BG BG105282A patent/BG65187B1/bg unknown
- 2001-02-21 HR HR20010128A patent/HRP20010128B1/xx not_active IP Right Cessation
- 2001-11-27 HK HK01108330A patent/HK1037531A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1037531A1 (en) | Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation method | |
DE69431807D1 (de) | Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung | |
CA2322875A1 (en) | A coated chewing gum, a method for preparation thereof and the use of one or more active substance(s) in solid form | |
CA2314078A1 (en) | Coating of polymers | |
HUT50050A (en) | Pharmaceutical compositions with controlled release of active ingredient and process for producing such compositions | |
AU3100700A (en) | Antibiotic hydrophilic polymer coating | |
CA2348398A1 (en) | Water-soluble coating agents bearing initiator groups and coating process | |
CA2281420A1 (en) | Preparation of pharmaceutically-active granules | |
EP0351760A3 (de) | Futterzusatzmittel für Wiederkäuer | |
DE69100670D1 (de) | Eine Suspension hydratisierter Spheroide einer hydrophilen Lipidsubstanz enthaltendes wässriges kosmetisches bzw. dermopharmazeutisches Mittel. | |
AU2307402A (en) | Microgranules based on active principle and method for making same | |
AU1470195A (en) | Nanoparticles containing an active substance and a ketalizedpolytartramidic acid, process for their preparation, and use thereof | |
AU5942694A (en) | A solid pharmaceutical dosage form and a method for reducing abrasion | |
EP0998944A3 (de) | Enterisch überzogene Formulierung eines Benzimidazol-Derivates und Verfahren deren Herstellung | |
AU5320998A (en) | Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production | |
AU692030B2 (en) | Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients | |
ES8800838A1 (es) | Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090720 |